SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-023767
Filing Date
2022-06-21
Accepted
2022-06-21 16:30:36
Documents
12
Period of Report
2022-06-16
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K nuvl-8k_20220616.htm   iXBRL 8-K 49867
  Complete submission text file 0001564590-22-023767.txt   182142

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nuvl-20220616.xsd EX-101.SCH 5589
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nuvl-20220616_lab.xml EX-101.LAB 20063
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nuvl-20220616_pre.xml EX-101.PRE 11934
6 EXTRACTED XBRL INSTANCE DOCUMENT nuvl-8k_20220616_htm.xml XML 3675
Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Filer) CIK: 0001861560 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40671 | Film No.: 221028506
SIC: 2834 Pharmaceutical Preparations